CRPPA

CDP-L-ribitol pyrophosphorylase A; Dystroglycanopathy-associated gene

Gene Information Card

Symbol CRPPA
Full Name CDP-L-ribitol pyrophosphorylase A
Gene Type Protein coding
Chromosomal Location 7p21.2
NCBI Gene ID 729920 ncbi.nlm.nih.gov/gene/729920
Ensembl ID ENSG00000182378
UniProt ID Q5T6W5
OMIM ID 614631
HGNC ID 37276
Aliases ISPD, MDDGA7, MDDGC7, MDDGB7

Description

The CRPPA gene encodes CDP-L-ribitol pyrophosphorylase A, an enzyme involved in the biosynthesis of CDP-ribitol, a nucleotide sugar required for the O-mannosylation of alpha-dystroglycan. This post-translational modification is critical for the structural integrity of the extracellular matrix and muscle cell membrane. Mutations in CRPPA disrupt this glycosylation pathway, leading to a spectrum of dystroglycanopathies, including congenital muscular dystrophy and limb-girdle muscular dystrophy.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A7 Loss-of-function mutations impair CDP-ribitol synthesis, reducing alpha-dystroglycan glycosylation and disrupting basement membrane adhesion. OMIM #614643
Muscular dystrophy-dystroglycanopathy (limb-girdle) type C7 Hypomorphic mutations lead to partial loss of enzyme activity, causing milder limb-girdle muscular dystrophy phenotype. OMIM #616052
Muscular dystrophy-dystroglycanopathy (congenital without mental retardation) type B7 Biallelic mutations with residual enzyme activity result in congenital muscular dystrophy without significant brain involvement. OMIM #616052

Expression Profile

Tissue Expression
Tissue nTPM level
Skeletal muscle 8.2 Medium
Heart 6.5 Medium
Brain 4.1 Low
Liver 2.3 Low
Kidney 3.0 Low
Cell Line Expression
Cell Line nTPM Notes
Skeletal muscle myoblasts 7.8 Differentiated cells show higher expression
Cardiomyocytes 6.1 Consistent with heart tissue data
Fibroblasts 2.5 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.100G>A (p.Gly34Arg) Missense Rare Reduced enzyme activity; associated with LGMD
c.1342C>T (p.Arg448*) Nonsense Rare Loss of function; severe congenital phenotype
c.1A>G (p.Met1?) Start loss Rare Complete loss of protein; severe dystroglycanopathy
Mutation functional classification

Loss of Function (LOF)

Most CRPPA mutations are loss-of-function, reducing or abolishing CDP-ribitol synthesis and alpha-dystroglycan glycosylation.

Gain of Function (GOF)

No gain-of-function mutations reported.

Dominant Negative (DN)

No dominant-negative mutations reported; disease is autosomal recessive.

Pathways

O-mannosyl glycan biosynthesis (Reactome R-HSA-5173105)
Dystroglycan-related disorders (KEGG hsa05310)

Protein Summary

CRPPA encodes a 448-amino acid protein localized to the Golgi apparatus. It catalyzes the formation of CDP-ribitol from CTP and ribitol-5-phosphate, providing the ribitol phosphate donor for the synthesis of the O-mannosyl glycan on alpha-dystroglycan. This modification is essential for binding to extracellular matrix proteins such as laminin. Deficiency leads to reduced glycosylation and muscular dystrophy phenotypes.

Related Products

Product name Cat.No. Species Gene ID
CRPPA Knockout HEK293 Cell Line EDJ-KQ13005 Human 729920 Details Get a Quote
CRPPA Knockout HCT 116 Cell Line EDJ-KQ41020 Human 729920 Details Get a Quote
CRPPA Knockout A-549 Cell Line EDJ-KQ42264 Human 729920 Details Get a Quote
Displaying Records 1 To 3 Of 3 Records
Contact Us
*
*
*
*
How did you hear about us: